Abstract
In neonatal pneumonia, the surface activity of pulmonary surfactant is impaired and microorganisms may invade by passing the air-liquid interface. Previously, we have shown that addition of the antimicrobial peptide polymyxin B (PxB) to modified porcine surfactant (pSF) improves resistance to surfactant inactivation in vitro while antimicrobial activity of PxB is maintained. In this study, we investigated pSF/PxB in vivo. Neonatal near-term rabbits were treated with intratracheal pSF and/or PxB. Rabbits treated with only saline served as controls. Animals were ventilated with standardized tidal volumes and received ∼107 E scherichia coli intratracheally. Plethysmographic pressure-volume curves were recorded every 30 min. After 240 min, animals were killed, the right lung and left kidney were excised, and bacterial growth was determined. The left lung was used for histologic analysis. Intratracheal administration of PxB ± pSF significantly reduced the growth of E. coli compared with control animals or animals receiving only pSF. This was accompanied by reduction of severe inflammatory tissue destruction and significantly reduced bacterial translocation to the left kidney. Animals receiving pSF + PxB had no difference in lung compliance compared with the pSF- or PxB-treated group. Mixtures of PxB and pulmonary surfactant show antimicrobial effects in neonatal rabbits and prevent systemic spreading of E. coli.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- ARDS:
-
acute respiratory distress syndrome
- CFU:
-
colony-forming units
- LPS:
-
lipopolysaccharide, endotoxin
- pSF:
-
modified porcine surfactant
- PxB:
-
polymyxin B
- V T :
-
tidal volume
References
Sarkar S, DeSantis ER, Kuper J 2007 Resurgence of colistin use. Nephrotoxic, neurotoxic effects of polymyxins. Am J Health Syst Pharm 64: 2462–2466
Falagas ME, Kasiakou SK 2006 Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 10: R27
Robertson B, Schürch S 1998 Assessment of surfactant function. In: Uhlig S, Taylor AE (eds) Methods in Pulmonary Research. Birkäuser Verlag, Basel, Switzerland, pp 349–383
Taeusch HW, Keough KM 2001 Inactivation of pulmonary surfactant and the treatment of acute lung injuries. Pediatr Pathol Mol Med 20: 519–536
Taut FJ, Rippin G, Schenk P, Findlay G, Wurst W, Häfner D, Lewis JF, Seeger W, Günther A, Spragg RG 2008 A Search for subgroups of patients with ARDS who may benefit from surfactant replacement therapy: a pooled analysis of five studies with recombinant surfactant protein-C surfactant (Venticute). Chest 134: 724–732
Stichtenoth G, Jung P, Johansson J, Robertson B, Curstedt T, Herting E 2006 Polymyxin B/pulmonary surfactant mixtures have increased resistance to inactivation by meconium and reduce growth of Gram-negative bacteria in vitro. Pediatr Res 59: 407–411
Sun B, Kobayashi T, Cursted T, Grossmann G, Robertson B 1991 Application of a new ventilator-multi-plethysmograph system for testing efficacy of surfactant replacement in newborn rabbits. Eur Respir J 4: 364–370
Stichtenoth G, Linderholm B, Almlén A, Björkman MH, Byman I, Nordling K, Robertson B, Johansson J, Herting E, Curstedt T 2009 Inactivation of pulmonary surfactant by silicone oil in vitro and in ventilated immature rabbits. Crit Care Med 37: 1750–1756
Johansson J, Some M, Linderholm BM, Almlén A, Curstedt T, Robertson B 2003 A synthetic surfactant based on a poly-Leu SP-C analog and phospholipids: effects on tidal volumes and lung gas volumes in ventilated immature newborn rabbits. J Appl Physiol 95: 2055–2063
Stoll BJ, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R, Laptook A, Walsh M, Oh W, Hale E 2005 National Institute of Child Health and Human Development: very low birth weight preterm infants with early onset neonatal sepsis: the predominance of Gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network 2002–2003. Pediatr Infect Dis J 24: 635–639
Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK 2002 Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 347: 240–247
Schrag SJ, Stoll BJ 2006 Early-onset neonatal sepsis in the era of widespread intrapartum chemoprophylaxis. Pediatr Infect Dis J 25: 939–940
Falagas ME, Kasiakou SK 2005 Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis 40: 1333–1341
Evans ME, Feola DJ, Rapp RP 1999 Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant Gram-negative bacteria. Ann Pharmacother 33: 960–967
van't Veen A, Mouton JW, Gommers D, Lachmann B 1996 Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae. Br J Pharmacol 119: 1145–1148
van 't Veen A, Gommers D, Mouton JW, Kluytmans JA, Krijt EJ, Lachmann B 1996 Exogenous pulmonary surfactant as a drug delivering agent: influence of antibiotics on surfactant activity. Br J Pharmacol 118: 593–598
Cajal Y, Ghanta J, Easwaran K, Surolia A, Jain MK 1996 Specificity for the exchange of phospholipids through polymyxin B mediated intermembrane molecular contacts. Biochemistry 35: 5684–5695
Zaltash S, Palmblad M, Curstedt T, Johansson J, Persson B 2000 Pulmonary surfactant protein B a structural model and a functional analogue. Biochim Biophys Acta 1466: 179–186
Omri A, Suntres ZE, Shek PN 2002 Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem Pharmacol 64: 1407–1413
Calkovska A, Some M, Linderholm B, Johansson J, Curstedt T, Robertson B 2005 Biophysical and physiological properties of porcine surfactant enriched with polymyxin B. Biol Neonate 88: 101–108
Flieger A, Gongab S, Faigle M, Mayer HA, Kehrer U, Mussotter J, Bartmann P, Neumeister B 2000 Phospholipase A secreted by Legionella pneumophila destroys alveolar surfactant phospholipids. FEMS Microbiol Lett 188: 129–133
Wheeldon EB, Walker ME, Murphy DJ, Turner CR 1992 Intratracheal aerosolization of endotoxin in the rat: a model of the adult respiratory distress syndrome (ARDS). Lab Anim 26: 29–37
van Helden HP, Kuijpers WC, Steenvoorden D, Go C, Bruijnzeel PL, van Eijk M, Haagsman HP 1997 Intratracheal aerosolization of endotoxin (LPS) in the rat: a comprehensive animal model to study adult (acute) respiratory distress syndrome. Exp Lung Res 23: 297–316
Fox-Dewhurst R, Alberts MK, Kajikawa O, Caldwell E, Johnson MC II, Skerrett SJ, Goodman RB, Ruzinski JT, Wong VA, Chi EY, Martin TR 1997 Pulmonary and systemic inflammatory responses in rabbits with gram-negative pneumonia. Am J Respir Crit Care Med 155: 2030–2040
Tremblay LN, Slutsky AS 1998 Ventilator-induced injury: from barotrauma to biotrauma. Proc Assoc Am Physicians 110: 482–488
Uhlig S, Frerichs I 2008 Lung protective ventilation-pathophysiology and diagnostics. Anasthesiol Intensivmed Notfallmed Schmerzther 43: 438–445
van Kaam AH, Lutter R, Lachmann RA, Haitsma JJ, Herting E, Snoek M, De Jaegere A, Kok JH, Lachmann B 2005 Effect of ventilation strategy and surfactant on inflammation in experimental pneumonia. Eur Respir J 26: 112–117
Lachmann RA, van Kaam AH, Haitsma JJ, Lachmann B 2007 High positive end-expiratory pressure levels promote bacterial translocation in experimental pneumonia. Intensive Care Med 33: 1800–1804
Danner RL, Joiner KA, Rubin M, Patterson WH, Johnson N, Ayers KM, Parrillo JE 1989 Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide. Antimicrob Agents Chemother 33: 1428–1434
Manocha S, Feinstein D, Kumar A, Kumar A 2002 Novel therapies for sepsis: antiendotoxin therapies. Expert Opin Investig Drugs 11: 1795–1812
van Rozendaal BA, van de Lest CH, van Eijk M, van Golde LM, Voorhout WF, van Helden HP, Haagsman HP 1999 Aerosolized endotoxin is immediately bound by pulmonary surfactant protein D in vivo. Biochim Biophys Acta 1454: 261–269
Ikegami M, Carter K, Bishop K, Yadav A, Masterjohn E, Brondyk W, Scheule RK, Whitsett JA 2006 Intratracheal recombinant surfactant protein D prevents endotoxin shock in the newborn preterm lamb. Am J Respir Crit Care Med 173: 1342–1347
Stamme C, Wright JR 1999 Surfactant protein A enhances the binding and deacylation of E. coli LPS by alveolar macrophages. Am J Physiol 276: L540–L547
van Helden HP, Kuijpers WC, Langerwerf PE, Langen RC, Haagsman HP, Bruijnzeel PL 1998 Efficacy of Curosurf in a rat model of acute respiratory distress syndrome. Eur Respir J 12: 533–539
Thomassen MJ, Meeker DP, Antal JM, Connors MJ, Wiedemann HP 1992 Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am J Respir Cell Mol Biol 7: 257–260
Thomassen MJ, Antal JM, Barna BP, Divis LT, Meeker DP, Wiedemann HP 1996 Surfactant downregulates synthesis of DNA and inflammatory mediators in normal human lung fibroblasts. Am J Physiol 270: L159–L163
Herting E, Jarstrand C, Rasool O, Curstedt T, Sun B, Robertson B 1994 Experimental neonatal group B streptococcal pneumonia: effect of a modified porcine surfactant on bacterial proliferation in ventilated near-term rabbits. Pediatr Res 36: 784–791
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the Swedish Research Council (Project No. 3351), The Swedish Heart Lung Foundation and the German Research Council (DFG He 2072/2–2) and the PPP-Program of the German Academic Exchange Service, DAAD, Project No.: PPP-SE and Chiesi Farmaceutici S.p.A.
Rights and permissions
About this article
Cite this article
Stichtenoth, G., Linderholm, B., Björkman, M. et al. Prophylactic Intratracheal Polymyxin B/Surfactant Prevents Bacterial Growth in Neonatal Escherichia coli Pneumonia of Rabbits. Pediatr Res 67, 369–374 (2010). https://doi.org/10.1203/PDR.0b013e3181d026f6
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/PDR.0b013e3181d026f6
This article is cited by
-
Restoration of surfactant activity by polymyxin B in lipopolysaccharide-potentiated injury of immature rabbit lungs
Scientific Reports (2021)
-
Properties of modified natural surfactant after exposure to fibrinogen in vitro and in an animal model of respiratory distress syndrome
Pediatric Research (2012)
